TrialMultiple sclerosis (Houndmills, Basingstoke, England)2022

Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study.

Corey C Ford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.